These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 16436709)
1. Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor. Victoriano AF; Asamitsu K; Hibi Y; Imai K; Barzaga NG; Okamoto T Antimicrob Agents Chemother; 2006 Feb; 50(2):547-55. PubMed ID: 16436709 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 replication by blocking IkappaB kinase with noraristeromycin. Asamitsu K; Yamaguchi T; Nakata K; Hibi Y; Victoriano AF; Imai K; Onozaki K; Kitade Y; Okamoto T J Biochem; 2008 Nov; 144(5):581-9. PubMed ID: 18713798 [TBL] [Abstract][Full Text] [Related]
3. NF-κB-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-κB Signaling. Wang H; Liu Y; Huan C; Yang J; Li Z; Zheng B; Wang Y; Zhang W J Virol; 2020 Aug; 94(17):. PubMed ID: 32581100 [TBL] [Abstract][Full Text] [Related]
4. Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. Traber KE; Okamoto H; Kurono C; Baba M; Saliou C; Soji T; Packer L; Okamoto T Int Immunol; 1999 Feb; 11(2):143-50. PubMed ID: 10069412 [TBL] [Abstract][Full Text] [Related]
5. Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor. Sanda T; Asamitsu K; Ogura H; Iida S; Utsunomiya A; Ueda R; Okamoto T Leukemia; 2006 Apr; 20(4):590-8. PubMed ID: 16453001 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride. Sato T; Asamitsu K; Yang JP; Takahashi N; Tetsuka T; Yoneyama A; Kanagawa A; Okamoto T AIDS Res Hum Retroviruses; 1998 Mar; 14(4):293-8. PubMed ID: 9519889 [TBL] [Abstract][Full Text] [Related]
7. de Jesus MSM; Macabeo APG; Ramos JDA; de Leon VNO; Asamitsu K; Okamoto T Molecules; 2022 Feb; 27(3):. PubMed ID: 35164343 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct. Muto NF; Martinand-Mari C; Adelson ME; Suhadolnik RJ J Virol; 1999 Nov; 73(11):9021-8. PubMed ID: 10516008 [TBL] [Abstract][Full Text] [Related]
9. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation. Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450 [TBL] [Abstract][Full Text] [Related]
10. Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds. Barbeau B; Bernier R; Dumais N; Briand G; Olivier M; Faure R; Posner BI; Tremblay M J Biol Chem; 1997 May; 272(20):12968-77. PubMed ID: 9148903 [TBL] [Abstract][Full Text] [Related]
11. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. Quivy V; Adam E; Collette Y; Demonte D; Chariot A; Vanhulle C; Berkhout B; Castellano R; de Launoit Y; Burny A; Piette J; Bours V; Van Lint C J Virol; 2002 Nov; 76(21):11091-103. PubMed ID: 12368351 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of herpesvirus-induced HIV-1 replication by cyclopentenone prostaglandins: role of IkappaB kinase (IKK). Amici C; Belardo G; Rozera C; Bernasconi D; Santoro MG AIDS; 2004 Jun; 18(9):1271-80. PubMed ID: 15362659 [TBL] [Abstract][Full Text] [Related]
13. 3-Formylchromone interacts with cysteine 38 in p65 protein and with cysteine 179 in IκBα kinase, leading to down-regulation of nuclear factor-κB (NF-κB)-regulated gene products and sensitization of tumor cells. Yadav VR; Prasad S; Gupta SC; Sung B; Phatak SS; Zhang S; Aggarwal BB J Biol Chem; 2012 Jan; 287(1):245-256. PubMed ID: 22065587 [TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells. Okamoto M; Ono M; Baba M AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1239-45. PubMed ID: 9764907 [TBL] [Abstract][Full Text] [Related]
15. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB. Yang X; Chen Y; Gabuzda D J Biol Chem; 1999 Sep; 274(39):27981-8. PubMed ID: 10488148 [TBL] [Abstract][Full Text] [Related]
16. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway. Zhang HS; Wu TC; Sang WW; Ruan Z Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519 [TBL] [Abstract][Full Text] [Related]
17. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Tse AK; Wan CK; Shen XL; Yang M; Fong WF Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613 [TBL] [Abstract][Full Text] [Related]
18. Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation. Muñoz-Fernández MA; Navarro J; Garcia A; Punzón C; Fernández-Cruz E; Fresno M J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):838-45. PubMed ID: 9438495 [TBL] [Abstract][Full Text] [Related]